TBA Law Blog

Posted by: Stacey Shrader Joslin on Jun 24, 2013

The Supreme Court also ruled today that generic drug manufacturers cannot be sued in state court for a drug design defect if federal officials approved the brand-name version that the generic drug copied. The justices voted 5-4 to agree with generic manufacturer Mutual Pharmaceutical Co. Inc., which had asked that a $21 million judgment against it be dismissed. The Memphis Daily News has the story.